AS

Akshita Sharma

Active Director Director DIN 09037944
DIN 09037944 First appointment Aug 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Akshita Sharma

Data last updated:

Akshita Sharma is a Director at Jams Lifesciences Private Limited (since 2023). The company operates in Healthcare. Jams Lifesciences Private Limited reported revenue of ₹44.02 Cr (FY 2025).

DIN 09037944
Primary Designation Director
Industry Healthcare
First Appointment 30 Aug 2023
Oldest Company Age 5 yrs
Largest company Jams Lifesciences Private Limited · ₹44.02 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jams Lifesciences Private Limited U24290UR2021PTC011985
Director30 Aug 20232021₹44.02 Cr (FY 2025)Active

Board colleagues of Akshita Sharma

Directorship timeline

Open interactive timeline →
Jams Lifesciences Private Limited
Premium access

Shareholding and investment profile for Akshita Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshita Sharma

Akshita Sharma currently holds 1 directorship: Jams Lifesciences Private Limited (Director, since 30 Aug 2023, revenue ₹44.02 Cr (FY 2025)).

Akshita Sharma was first appointed on 30 Aug 2023 as Director at Jams Lifesciences Private Limited.

The current boards of Akshita Sharma's companies include Anuj Parashar (Jams Lifesciences Private Limited), Subhash Chand Sharma (Jams Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available